BINDA, ANNA
BINDA, ANNA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons
2013 Binda, A; Bana, L; Panariti, A; Minniti, S; Masserini, M; Re, F; Rivolta, I
Acetylation mediates Cx43 reduction caused by electrical stimulation
2015 Meraviglia, V; Azzimato, V; Colussi, C; Florio, M; Binda, A; Panariti, A; Qanud, K; Suffredini, S; Gennaccaro, L; Miragoli, M; Barbuti, A; Lampe, P; Gaetano, C; Pramstaller, P; Capogrossi, M; Recchia, F; Pompilio, G; Rivolta, I; Rossini, A
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype
2015 Bugiardini, E; Rivolta, I; Binda, A; Soriano Caminero, A; Cirillo, F; Cinti, A; Giovannoni, R; Botta, A; Cardani, R; Wicklund, M; Meola, G
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells
2017 Rivolta, I; Binda, A; Molteni, L; Rizzi, L; Bresciani, E; Possenti, R; Fehrentz, J; Verdié, P; Martinez, J; Omeljaniuk, R; Locatelli, V; Torsello, A
Relevance of electrolytic balance in channelopathies.
2017 Binda, A
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia
2017 Binda, A; Cardani, R; Renna, L; Fossati, B; Bosè, F; Botta, A; Valaperta, R; Meola, G; Rivolta, I
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells
2017 Molteni, L; Rizzi, L; Bresciani, E; Possenti, R; Petrocchi Passeri, P; Ghè, C; Muccioli, G; Fehrentz, J; Verdié, P; Martinez, J; Omeljaniuk, R; Biagini, G; Binda, A; Rivolta, I; Locatelli, V; Torsello, A
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1
2018 Binda, A; Rivolta, I; Villa, C; Chisci, E; Beghi, M; Cornaggia, C; Giovannoni, R; Combi, R
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease
2018 Binda, A; Panariti, A; Barbuti, A; Murano, C; Dal Magro, R; Masserini, M; Re, F; Rivolta, I
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond
2018 Marini, C; Porro, A; Rastetter, A; Dalle, C; Rivolta, I; Bauer, D; Oegema, R; Nava, C; Parrini, E; Mei, D; Mercer, C; Dhamija, R; Chambers, C; Coubes, C; Thévenon, J; Kuentz, P; Julia, S; Pasquier, L; Dubourg, C; Carré, W; Rosati, A; Melani, F; Pisano, T; Giardino, M; Innes, A; Alembik, Y; Scheidecker, S; Santos, M; Figueiroa, S; Garrido, C; Fusco, C; Frattini, D; Spagnoli, C; Binda, A; Granata, T; Ragona, F; Freri, E; Franceschetti, S; Canafoglia, L; Castellotti, B; Gellera, C; Milanesi, R; Mancardi, M; Clark, D; Kok, F; Helbig, K; Ichikawa, S; Sadler, L; Neupauerová, J; Laššuthova, P; Šterbová, K; Laridon, A; Brilstra, E; Koeleman, B; Lemke, J; Zara, F; Striano, P; Soblet, J; Smits, G; Deconinck, N; Barbuti, A; Difrancesco, D; Leguern, E; Guerrini, R; Santoro, B; Hamacher, K; Thiel, G; Moroni, A; Di Francesco, J; Depienne, C
HCN1 novel mutations in familiar generalized epilepsy
2018 Binda, A; Murano, C; Granata, T; Ragona, F; Freri, E; Franceschetti, S; Canafoglia, L; Castellotti, B; Gellere, C; Milanesi, R; Difrancesco, J; Rivolta, I
SCN4A as modifier gene in patients with myotonic dystrophy type 2
2018 Binda, A; Renna, L; Bose', F; Brigonzi, E; Botta, A; Valaperta, R; Fossati, B; Rivolta, I; Meola, G; Cardani, R
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature
2019 Difrancesco, J; Castellotti, B; Milanesi, R; Ragona, F; Freri, E; Canafoglia, L; Franceschetti, S; Ferrarese, C; Magri, S; Taroni, F; Costa, C; Labate, A; Gambardella, A; Solazzi, R; Binda, A; Rivolta, I; Di Gennaro, G; Casciato, S; D'Incerti, L; Barbuti, A; Difrancesco, D; Granata, T; Gellera, C
Progressive epileptic encephalopathy associated with a novel HCN2 mutation
2019 Binda, A; Murano, C; DI FRANCESCO, J; Castellotti, B; Milanesi, R; Ragona, F; Freri, E; Canafoglia, L; Franceschetti, S; Solazzi, R; Granata, T; Gellera, C; Rivolta, I
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes
2019 Murano, C; Binda, A; Lucano, D; Micaglio, E; Ciconte, G; Ghiroldi, A; Anastasia, L; Pappone, C; Rivolta, I
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons
2020 Porro, A; Binda, A; Pisoni, M; Donadoni, C; Rivolta, I; Saponaro, A
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death
2020 Juang, J; Binda, A; Lee, S; Hwang, J; Chen, W; Liu, Y; Lin, L; Yu, C; Ho, L; Huang, H; Chen, C; Lu, T; Lai, L; Yeh, S; Lai, L; Chuang, E; Rivolta, I; Antzelevitch, C
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy
2020 Soldovieri, M; Freri, E; Ambrosino, P; Rivolta, I; Mosca, I; Binda, A; Murano, C; Ragona, F; Canafoglia, L; Vannicola, C; Solazzi, R; Granata, T; Castellotti, B; Messina, G; Gellera, C; Labalme, A; Lesca, G; Difrancesco, J; Taglialatela, M
Cardiac and neuronal HCN channelopathies
2020 Rivolta, I; Binda, A; Masi, A; Difrancesco, J
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020)
2020 Binda, A; Murano, C; Rivolta, I